Glenmede Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,228,287
Closed -$122K 3253
2019
Q3
$122K Sell
1,228,287
-12,100
-1% -$1.15M 0.56% 39
2019
Q2
$115K Sell
1,240,387
-12,912
-1% -$1.23M 0.5% 44
2019
Q1
$118K Sell
1,253,299
-89,051
-7% -$7.79M 0.53% 42
2018
Q4
$86K Buy
1,342,350
+261,488
+24% +$19.3M 0.42% 56
2018
Q3
$96.7M Buy
1,080,862
+702,573
+186% +$62.1M 0.39% 57
2018
Q2
$30M Sell
378,289
-401,758
-52% -$33.4M 0.13% 233
2018
Q1
$81.4M Hold
780,047
0.34% 71
2017
Q4
$81.4M Sell
780,047
-23,018
-3% -$2.6M 0.34% 71
2017
Q3
$117M Sell
803,065
-10,368
-1% -$1.41M 0.51% 43
2017
Q2
$101M Hold
813,433
0.48% 40
2017
Q1
$101M Buy
813,433
+365,300
+82% +$43.7M 0.48% 40
2016
Q4
$51.9M Buy
448,133
+2,690
+0.6% +$300K 0.28% 93
2016
Q3
$46.6M Sell
445,443
-137,740
-24% -$14.9M 0.26% 97
2016
Q2
$57.5M Buy
583,183
+47,397
+9% +$4.9M 0.35% 69
2016
Q1
$53.6M Sell
535,786
-4,298
-0.8% -$443K 0.35% 68
2015
Q4
$64.7M Sell
540,084
-26,898
-5% -$3.11M 0.44% 54
2015
Q3
$61.3M Buy
566,982
+46,747
+9% +$5.8M 0.45% 48
2015
Q2
$60.2M Buy
520,235
+142,534
+38% +$16.3M 0.43% 45
2015
Q1
$43.5M Buy
377,701
+65,848
+21% +$7.87M 0.32% 76
2014
Q4
$34.9M Buy
311,853
+10,734
+4% +$1.13M 0.27% 92
2014
Q3
$28.5M Buy
301,119
+16,270
+6% +$1.47M 0.25% 93
2014
Q2
$24.5M Sell
284,849
-33,401
-10% -$2.54M 0.22% 106
2014
Q1
$22.2M Buy
318,250
+60,178
+23% +$4.77M 0.21% 113
2013
Q4
$21.8M Buy
258,072
+2,398
+0.9% +$190K 0.22% 98
2013
Q3
$19.7M Buy
255,674
+11,106
+5% +$778K 0.23% 98
2013
Q2
$14.3M Buy
+244,568
New +$14.7M 0.18% 118

Other funds holding CELG

Glenmede Trust's CELG Position: Q4 2019 in Review

Glenmede Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,228,287 shares — an estimated $122K sold.

Glenmede Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $117M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Glenmede Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Glenmede Trust sold 1,228,287 Celgene Corp shares in Q4 2019, an estimated $122K.
  • Glenmede Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Glenmede Trust's Celgene Corp position peaked at $117M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.